The terms MSC and MSCs have become the preferred acronym to describe a cell and a cell
population of multipotential stem/progenitor cells commonly referred to as mesenchymal …

Cancer is a leading cause of death worldwide and, despite new targeted therapies and
immunotherapies, many patients with advanced-stage-or high-risk cancers still die, owing to …

Numbers of Hematopoietic cell transplantation (HCT) in Europe and collaborating countries
continues to rise with 48,512 HCT in 43,581 patients, comprising of 19,798 (41%) allogeneic …

The Worldwide Network of Blood and Marrow Transplantation (WBMT) pursues the mission
of promoting hematopoietic cell transplantation (HCT) for instance by evaluating activities …

When T cells from a bone marrow donor begin to attack the host within 3 months after
hematopoietic-cell transplantation, acute graft-versus-host disease results. The disease …

Introduction Multiple myeloma (MM) is a plasma cell neoplasm with substantial morbidity
and mortality. A comprehensive description of the global burden of MM is needed to help …

The first edition of the European LeukemiaNet (ELN) recommendations for diagnosis and
management of acute myeloid leukemia (AML) in adults, published in 2010, has found …

Abstract The European Society of Endodontology and the American Association for
Endodontists have released position statements and clinical considerations for regenerative …

Abstract Information on incidence, and factors associated with mortality is a prerequisite to
improve outcome after hematopoietic stem cell transplantation (HSCT). Therefore, 55′ 668 …

Abstract Purpose of Review Cryopreservation and its associated freezing and thawing
procedures–short “freeze-thawing”–are among the final steps in economically viable …